MR Imaging and MR Spectroscopy in Rhizomelic Chondrodysplasia Punctata

References

1. ↵
   Powers JM, Moser HW. Peroxisomal disorders: genotype, phenotype, major neuropathologic lesions and pathogenesis. Brain Pathol 1998;8:101–120

   PubMedWeb of Science
2. ↵
   Wanders RJA. Peroxisomal disorders: clinical, biochemical and molecular aspects. Neurochem Res 1999;24:565–580

   CrossRefPubMedWeb of Science
3. ↵
   Bruhn H, Kruse B, Korenke GC, et al. Proton NMR spectroscopy of cerebral metabolic alterations in infantile peroxisomal disorders. J Comput Assist Tomogr 1992;16:335–344

   PubMedWeb of Science
4. ↵
   Williams DW, Elster AD, Cox TD. Cranial MR imaging in rhizomelic chondrodysplasia punctata. AJNR Am J Neuroradiol 1991;12:363–365

   FREE Full Text
5. ↵
   Sztriha L, Al-Gazali LI, Wanders RJ, Ofman R, Nork M, Lestringant GG. Abnormal myelin formation in rhizomelic chondrodysplasia punctata type 2 (DHAPAT-deficiency). Dev Med Child Neurol 2000;42:492–495

   CrossRefPubMedWeb of Science
6. ↵
   van der Knapp MS, Valk J. The MR spectrum of peroxisomal disorder. Neuroradiology 1991;33:30–37

   CrossRefPubMedWeb of Science
7. ↵
   Lenti C, Paganoni P, Sangermani R. Rhizomelic chondrodysplasia punctata: 16-year follow-up of a child from birth. Ital J Neurol Sci 1991;12:469–473

   PubMed
8. ↵
   Kreis R, Ernst T, Ross BD. Development of the human brain: in vivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Res Med 1993;30:424–437

   CrossRefPubMedWeb of Science
9. Ross BD, Kreis R, Ernst T. Clinical for the 90s: magnetic resonance spectroscopy and metabolite imaging. Eur J Radiol 1992;14:128–140

   CrossRefPubMedWeb of Science
10. ↵
    Hüppi PS, Barnes PD. Magnetic resonance techniques in the evaluation of the newborn brain. Clin Perinatol 1997;24:693–723

    PubMed
11. ↵
    Grodd W, Krageloh-Mann I, Klose U, Sauter R. Metabolic and destructive brain disorders in children: findings with localized proton MR spectroscopy. Radiology 1991;181:173–181

    PubMedWeb of Science
12. ↵
    Maillet S, Vion-Dury J, Confort-Gouny S, et al. Experimental protocol for clinical analysis of cerebrospinal fluid by high resolution proton magnetic resonance spectroscopy. Brain Res Brain Res Protoc 1998;3:123–134

    CrossRefPubMedWeb of Science
13. ↵
    Pouwels PJ, Kruse B, Korenke GC, Mao X, Hanefeld FA, Frahm J. Quantitative proton magnetic resonance spectroscopy of childhood adrenoleukodystrophy. Neuropediatrics 1998;29:254–264

    CrossRefPubMed
14. ↵
    Confort-Gouny S, Vion-Dury J, Chabrol B, Nicoli F, Cozzone PJ. Localised proton magnetic resonance spectroscopy in X-linked adrenoleukodystrophy. Neuroradiology 1995;37:568–575

    PubMedWeb of Science
15. ↵
    Hajra AK. Dihydroxyacetone phosphate acyltransferase. Biochim Biophys Acta 1997; 1348:27–34

    PubMed
16. ↵
    Rizzo WB, Craft DA, Judd LL, Moser HW, Moser AB. Fatty alcohol accumulation in the autosomal recessive form of rhizomelic chondrodysplasia punctata. Biochem Med Metab Biol 1993;50:93–102

    CrossRefPubMedWeb of Science
17. ↵
    Edmond J. Energy metabolism in developing brain cells. Can J Physiol Pharmacol 1992;70(suppl):S118–S129
18. ↵
    Martin M, Merle M, Labouesse J, Canioni P. Postnatal decrease of acetate concentration in rat cerebellum. J Neurosci Res 1994;37:103–107

    PubMed
19. ↵
    Auestad N, Korsak RA, Morrow JW, Edmond J. Fatty acid oxidation and ketogenesis by astrocytes in primary culture. J Neurochem 1991;56:1376–1386

    CrossRefPubMedWeb of Science